Receptor-Ck regulates the expression of cyclin-dependent kinase inhibitors (p16; p27)

被引：0
|
作者：
D. Kaul
M. Kaur
机构：
[1] Postgraduate Institute of Medical Education and Research,Molecular Biology Unit, Department of Experimental Medicine and Biotechnology
来源：
Molecular and Cellular Biochemistry | 1999年 / 200卷
关键词：
mevalonate pathway; CDK inhibitors; Receptor-C; expression; TPA; HL-60 cell line;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The present study was addressed to understand the interrelationship between Receptor-Ck induction-activation coupling; isoprenoids (derived from mevalonate pathway) and cyclin-dependent kinase inhibitors. The results reported here unambiguously reveal that isoprenoids regulate the expression of genes coding for CDK inhibited p16 and p27. Further, Receptor-Ck dependent signalling, known to control the mevalonate pathway, had a direct effect upon the p27 gene expression. Based upon these studies coupled with our earlier findings we propose that Receptor-Ck has an important role in the regulation of cell cycle machinery.
引用
收藏
页码：183 / 186
页数：3
相关论文
共 50 条
  • [21] Evaluation of RB gene and cyclin-dependent kinase inhibitors p21 and p27 in pleomorphic xantoastrocytoma
    Begnami, MD
    Rushing, EJ
    Evangelista, R
    Santi, M
    Quezado, M
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2006, 14 (02) : 113 - 118
  • [22] Downregulation of cyclin-dependent kinase inhibitors p21 and p27 in pressure-overload hypertrophy
    Li, JM
    Brooks, G
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 273 (03): : H1358 - H1367
  • [23] Molecular characterization of the cyclin-dependent kinase inhibitor p27 promoter
    Zhang, Y.
    Lin, S.-C.
    B B A - Biomembranes, 1353 (03):
  • [24] Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation
    A Alessandrini
    DS Chiaur
    M Pagano
    Leukemia, 1997, 11 : 342 - 345
  • [25] Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation
    Alessandrini, A
    Chiaur, DS
    Pagano, M
    LEUKEMIA, 1997, 11 (03) : 342 - 345
  • [26] DEVELOPMENT OF MONOCLONAL-ANTIBODIES TO THE P16 AND P27 CYCLIN/CDK INHIBITORS
    MONELL, CR
    JIN, LP
    SHI, L
    SANG, BC
    HUANG, ECM
    SINGH, S
    FASEB JOURNAL, 1995, 9 (04): : A1066 - A1066
  • [27] Expression and proteasome-dependent degradation of cyclin-dependent kinase inhibitor p27 in leukemias.
    Gregorj, C
    Petrucci, MT
    Ariola, C
    Ricciardi, MR
    Mercurio, C
    Dominguez, JE
    Draetta, G
    Tafuri, A
    BLOOD, 1997, 90 (10) : 215 - 215
  • [28] Expression of p16 and cyclin-dependent kinase 4 proteins in primary breast carcinomas
    Ito, Y
    Kobayashi, T
    Takeda, T
    Nakano, Y
    Tamaki, Y
    Komoike, Y
    Wakasugi, E
    Shin, E
    Takatsuka, Y
    Kikkawa, N
    Matsuura, N
    Monden, M
    ONCOLOGY, 1997, 54 (06) : 508 - 515
  • [29] Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer
    Masciullo, V
    Sgambato, A
    Pacilio, C
    Pucci, B
    Ferrandina, G
    Palazzo, J
    Carbone, A
    Cittadini, A
    Mancuso, S
    Scambia, G
    Giordano, A
    CANCER RESEARCH, 1999, 59 (15) : 3790 - 3794
  • [30] Control of cyclin-dependent kinase inhibitor p27 expression by cap-independent translation
    Miskimins, WK
    Wang, G
    Hawkinson, M
    Miskimins, R
    MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (15) : 4960 - 4967
12345